Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
about
Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNSRegenerative Capacity of Macrophages for RemyelinationImaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple SclerosisRemyelination Therapy in Multiple SclerosisHyaluronan Synthesis, Catabolism, and Signaling in Neurodegenerative DiseasesGlial development: the crossroads of regeneration and repair in the CNSRemyelination therapy for multiple sclerosisPromoting myelin repair and return of function in multiple sclerosisPromoting remyelination in multiple sclerosis-recent advancesGain of Olig2 function in oligodendrocyte progenitors promotes remyelination.The polarity protein Scribble regulates myelination and remyelination in the central nervous systemTGFbeta1 stimulates the over-production of white matter astrocytes from precursors of the "brain marrow" in a rodent model of neonatal encephalopathyThe Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS MyelinationTaking Advantage of Nature's Gift: Can Endogenous Neural Stem Cells Improve Myelin Regeneration?The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple SclerosisPrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesThe oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelinationParadoxical dysregulation of the neural stem cell pathway sonic hedgehog-Gli1 in autoimmune encephalomyelitis and multiple sclerosisAnti-heat shock protein 90beta antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosisOlig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiationThyroid hormone administration enhances remyelination in chronic demyelinating inflammatory diseaseIntegrins direct Src family kinases to regulate distinct phases of oligodendrocyte developmentDysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNSZFP191 is required by oligodendrocytes for CNS myelinationIdentification of VHY/Dusp15 as a regulator of oligodendrocyte differentiation through a systematic genomics approachFSD-C10, a Fasudil derivative, promotes neuroregeneration through indirect and direct mechanismsActivation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells.Oligodendrocytes: biology and pathologyAge-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiencyOestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosisGlial grafting for demyelinating disease.Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learningAdvanced MRI and staging of multiple sclerosis lesionsMeasuring longitudinal myelin water fraction in new multiple sclerosis lesions.Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls.Actomyosin contractility controls cell surface area of oligodendrocytes.Combination of electroacupuncture and grafted mesenchymal stem cells overexpressing TrkC improves remyelination and function in demyelinated spinal cord of rats.Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.Retinoid X receptor gamma signaling accelerates CNS remyelination.
P2860
Q24645412-78B9BD46-5C04-4798-B785-CEFDC3B17790Q26744475-5DA460CF-1891-4BB6-AC74-3B47020B667DQ26744629-BF2B9AC2-C111-46B8-A3C4-38D90FB7B913Q26772359-8309E411-DAE0-46BE-B92B-A07D8DD97BBAQ26786074-E871D821-0C8A-4B11-A831-2C64C79FEE92Q26823697-1FF1A1E6-83E8-4391-A818-E5F06327A959Q26824246-7E51F519-43F2-4459-B430-916CC41719C9Q26862803-EF1C36E5-DE7A-462F-863D-40FA9653E97AQ27010398-6E6A5964-4030-4BF0-B6E0-792F79ED2EEEQ27303918-E7935ACC-52FC-4527-9C2A-E1C13C29E1C5Q27312603-43CE0E5F-FAE2-465D-A09E-5CA7FCD0EB08Q27333559-AE0A9DA2-803A-45A2-833B-091D286492CBQ27342581-4EB60F76-F50F-4196-B12D-26A8929B313EQ28072282-2634B942-2C61-40F5-90FE-33A9DBED7F70Q28073377-BB811990-F031-4F39-9888-13DFD821B78BQ28078621-21D8397A-0DCB-4113-9D04-5C726C651191Q28261757-49CCF456-9A7A-469A-BABC-47EA7F14F160Q28300184-C0ADC56F-69AB-4951-B33B-A9FFF0CE2B4AQ28564617-51336576-6D16-4261-8E5E-F4BA5E4FCF63Q28572838-9005F88F-348F-4688-8ED2-7A65BF11F42FQ28581342-3C9FF7B5-C935-4793-8A03-D0471CB50AEFQ28582937-8D0F6AA4-D356-4B44-99BF-764A35D77A46Q28589814-6A02A772-B5AB-4D03-B108-9DC69087476BQ28593364-1614FF4A-05AB-42BC-BF95-E45F43C52D94Q28727258-B6B4881F-5BCA-40ED-AB1E-B35EF26A607CQ28818583-1B10E545-9FEB-428D-82A5-CE2A0062AD2EQ29568315-3A3989E5-4C1E-4B85-A850-EB2B90A46FABQ30051584-F1F70D03-DB5B-424D-85A6-9056C3EB09FCQ30052479-88E18B15-9784-4112-A223-2EDCC252224DQ30479247-2A789B4B-4FA9-4769-A15A-1A9E99BD41EDQ30485292-AA0CC2E3-DC4B-44F6-99FE-F3A9BC24FBA7Q30500898-B3255280-C7B8-495E-ACF4-84A700297171Q30806734-E09D8636-4CCA-4361-8247-750BE4F0C541Q30825494-1BAD25EB-41DF-4D57-BD48-5249DCE5F595Q31027246-B78F9231-B984-4359-9D90-95CAB90CDDA5Q33288189-9836E899-24E0-47AE-B172-D27453B233F0Q33506767-7C694B4E-D349-46BF-BFD5-8FDBF1909EF6Q33562398-17ADBCA4-1433-4C7E-B0B9-AD930D7948CAQ33569781-81063CE5-95B1-47E0-A43D-DF2088CFE2CEQ33580095-174A3BAB-F154-4F40-ABA7-FC8C73F130E0
P2860
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
@ast
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
@en
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
@nl
type
label
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
@ast
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
@en
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
@nl
prefLabel
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
@ast
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
@en
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
@nl
P2093
P356
P1476
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
@en
P2093
Ansi Chang
Bruce D Trapp
Richard Rudick
Wallace W Tourtellotte
P304
P356
10.1056/NEJMOA010994
P407
P577
2002-01-01T00:00:00Z